Silicon Motion (S9M) Risk Analysis
Risk Overview Q4, 2022
Source: the company's latest filing for the period ended Dec 31, 2022, filed Apr 28, 2023
Risk Change Over Time
- Share Price & Shareholder Rights - Risk 1Our shareholders could file claims challenging the Merger, which may delay or prevent the closing of the Merger and may cause us to incur substantial defense or settlement costs, or otherwise adversely affect us.
Our shareholders may file lawsuits challenging the Merger. The outcome of any claim and / or litigation is uncertain. Such litigation, if not resolved, could prevent or delay completion of the Merger and result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers. One of the conditions to the closing of the Merger is the absence of any provision of applicable law or order by any governmental entity that has the effect of restraining, enjoining or otherwise prohibiting the consummation of the Merger. Therefore, if a plaintiff were successful in obtaining an injunction prohibiting the consummation of the Merger on the agreed-upon terms, then such injunction may prevent the Merger from being completed, or from being completed within the expected timeframe. The defense or settlement of any lawsuit or claim that remains unresolved at the time the Merger is completed may adversely affect the Company's business, financial conditions, results of operations and cash flows.
- Share Price & Shareholder Rights - Risk 2The restrictions on our ability to solicit or engage in negotiations with respect to other potential acquisition proposals may discourage other potential transactions that may be favorable to our shareholders.
Until the Merger is completed or the Merger Agreement is terminated, the Merger Agreement generally prohibits us from soliciting, encouraging or engaging in negotiations with respect to acquisition proposals or other business combinations.
- Share Price & Shareholder Rights - Risk 3Some of our directors and officers may have interests that may be different from, or in addition to, the interests of our shareholders.
Certain of the Company's officers and directors may have interests in the transactions contemplated by the Merger Agreement that may be different from, or in addition to, those of the Company's other shareholders,which interests are described in the Merger Proxy Statement. These interests include, among other things, the rights to accelerated vesting of equity awards, the indemnification and insurance and certain payments and benefits provisions contained in or permitted by the Merger Agreement.
- Corporate Activity and Growth - Risk 4If the Merger is not consummated by the Outside Date, either we or MaxLinear may, under certain circumstances that may be beyond our control, choose not to proceed with the Merger.
The Merger is subject to the satisfaction or waiver of certain closing conditions described in the Merger Proxy Statement and set forth in the Merger Agreement. The fulfillment of certain of these conditions is beyond our control, such as, (1) approval by Nasdaq of the listing of the shares of MaxLinear common stock to be issued in the Merger, (2) the absence of certain orders that restrain, enjoin or prohibit the consummation of the Merger, (3) the expiration or termination of the applicable waiting period under the HSR Act and (4) the receipt of clearance SAMR. If the Merger has not been completed by the Outside Date, either the Company or MaxLinear may generally terminate the Merger Agreement, notwithstanding the prior receipt of the approval of the Merger by the Company's shareholders, except that the right to terminate the Merger Agreement would not be available to a party that is in material breach of the Merger Agreement or whose actions or omissions, which constitute a breach of the Merger Agreement, are a principal cause of, or primarily result in, the failure of the Merger to be completed on or before that date.
- Corporate Activity and Growth - Risk 5The fact that there is a Merger pending could materially impact our business and results of operations.
While the Merger is pending, we are subject to a number of risks that may harm our business and results of operations, including: - the diversion of management and employee attention from implementing growth strategies in existing markets or in new markets that we are targeting;- potential diversion of public attention from the positioning of our independent brand and products in a manner that appeals to customers;- the fact that we will continue to incur expenses related to the Merger prior to its closing;- our potential inability to respond effectively to competitive pressures, industry developments and future opportunities, in particular, given certain restrictions on the conduct of our business during the interim period between signing and closing of the Merger due to pre-closing covenants in the Merger Agreement;- being subject to costly litigation associated with the Merger; and - our current and prospective employees may be uncertain about their future roles and relationships with us following completion of the Merger, which may adversely affect our ability to attract and retain key personnel.
- Corporate Activity and Growth - Risk 6The Merger may not be completed, due to the failure of the parties to achieve the closing conditions or otherwise; such a failure could negatively impact the price of our ADSs, our business, financial condition, and results of operations.
The Merger is subject to the satisfaction or waiver of certain closing conditions described in the Merger Agreement, including, among others: - approval by Nasdaq of the listing of the shares of MaxLinear common stock to be issued in the Merger;- the absence of certain orders that restrain, enjoin or prohibit the consummation of the Merger;- the expiration or termination of the applicable HSR Act waiting period and the receipt of clearance from SAMR;- subject to specified exceptions and qualifications for de minimis inaccuracies, materiality and material adverse effect, the accuracy of the representations and warranties with respect to the Company, MaxLinear and Merger Sub, except to the extent any such inaccuracy would not reasonably be expected to have a material adverse effect on the Company or MaxLinear;- compliance in all material respects by the Company, MaxLinear and Merger Sub with their respective covenants and agreements contained in the Merger Agreement; and - the absence of a continuing material adverse effect on the Company since the date of the Merger Agreement. Although the currently applicable HSR Act waiting period has expired, if the parties have not closed the Merger by June 27, 2023, they will need to re-file under the HSR Act. In addition, no assurance can be given that each of the other conditions will be satisfied. The Merger Agreement may also be terminated under the circumstances described in the Merger Proxy Statement. If the conditions are not satisfied or waived in a timely manner and the merger is delayed, payment of the transaction consideration will also be delayed. See "Explanatory Note". If the Merger is not completed (including in the case the Merger Agreement is terminated), our ongoing business may be adversely affected. Under such a scenario, our directors, senior management and other employees will have expended extensive time and effort and will have experienced significant distractions from their work, and we will have incurred significant transaction costs, during the pendency of a failed transaction. In addition, our continuing business relationships with business partners and employees, and the market's perceptions of our prospects, could be adversely affected, which could have a material adverse impact on the trading price of our ADSs. We also could be subject to litigation related to any failure to complete the Merger. If these risks materialize, our financial condition and results of operations could be materially adversely affected.
Risk Highlights Q4, 2022
Risk Word Cloud
Risk Factors Full Breakdown - Total Risks 37
- Share Price & Shareholder Rights - Risk 1Our stock price has been, and may continue to be, volatile, which could result in investors losing all or part of their investments.
Since we completed our initial public offering in June 2005, the market price of our ADSs has been and likely will continue to be highly volatile and could be subject to wide fluctuations in response to numerous factors, including but are not limited to the following: - actual or anticipated variations in our quarterly operating results or those of our competitors, customers, or NAND flash vendors;- actual or anticipated changes in NAND flash supply and demand dynamics;- actual or anticipated changes in our market share or the market share of our competitors;- the commencement or results of litigation;- short selling or market manipulation activities;- announcements by us, our competitors, our customers, or their other suppliers of new products or technological innovations;- changes in financial estimates or recommendations by securities analysts;- economic and social effects of the COVID-19 virus and the emergence of additional variants to the COVID-19 virus or other pandemics;- the payment or non-payment of cash dividends at the discretion of our board of directors;- the announcement and implementation of share repurchase programs;- announcements by us or our competitors of significant acquisitions, divestitures or partnerships; and - actual or anticipated changes in the global economic or industry outlook. Many of these factors are beyond our control and may negatively impact the market price of our ADSs, regardless of our performance. In addition, the stock market in general, and the market for technology and semiconductor companies in particular, have been highly volatile. Furthermore, the trading price of our ADSs may be adversely affected by third-parties trying to drive down the market price. Short sellers and others, some of whom post anonymously on social media, may be positioned to profit if our stock declines and their activities can negatively affect our stock price. These broad market and industry factors may seriously harm the market price of our ADSs, regardless of our operating performance. Our ADSs may not trade at the same price levels as that of other semiconductor and technology companies, and shares of semiconductor and technology companies, in general, may not sustain their current market prices. These fluctuations as well as general economic, political, and market conditions may have an adverse effect on the market price of our ADSs.
- Share Price & Shareholder Rights - Risk 2AddedOur shareholders could file claims challenging the Merger, which may delay or prevent the closing of the Merger and may cause us to incur substantial defense or settlement costs, or otherwise adversely affect us.
Our shareholders may file lawsuits challenging the Merger. The outcome of any claim and / or litigation is uncertain. Such litigation, if not resolved, could prevent or delay completion of the Merger and result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers. One of the conditions to the closing of the Merger is the absence of any provision of applicable law or order by any governmental entity that has the effect of restraining, enjoining or otherwise prohibiting the consummation of the Merger. Therefore, if a plaintiff were successful in obtaining an injunction prohibiting the consummation of the Merger on the agreed-upon terms, then such injunction may prevent the Merger from being completed, or from being completed within the expected timeframe. The defense or settlement of any lawsuit or claim that remains unresolved at the time the Merger is completed may adversely affect the Company's business, financial conditions, results of operations and cash flows.
- Share Price & Shareholder Rights - Risk 3AddedThe restrictions on our ability to solicit or engage in negotiations with respect to other potential acquisition proposals may discourage other potential transactions that may be favorable to our shareholders.
Until the Merger is completed or the Merger Agreement is terminated, the Merger Agreement generally prohibits us from soliciting, encouraging or engaging in negotiations with respect to acquisition proposals or other business combinations.
- Share Price & Shareholder Rights - Risk 4AddedSome of our directors and officers may have interests that may be different from, or in addition to, the interests of our shareholders.
Certain of the Company's officers and directors may have interests in the transactions contemplated by the Merger Agreement that may be different from, or in addition to, those of the Company's other shareholders,which interests are described in the Merger Proxy Statement. These interests include, among other things, the rights to accelerated vesting of equity awards, the indemnification and insurance and certain payments and benefits provisions contained in or permitted by the Merger Agreement.
See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.